Prescription drug Abilify 30mg tablets recalled for cross-product contamination
Abilify (aripiprazole) 30mg tablets are being recalled due to cross-contamination with other products. The affected lots were distributed nationwide in the United States.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA classified this as a Class III recall, which represents the lowest risk category for drug recalls. No illnesses or injuries are reported in the source documentation. The hazard involves theoretical cross-contamination with unspecified products, consistent with a precautionary, low-risk recall.
Plain-English summary
Otsuka America Pharmaceutical, Inc. is recalling Abilify (aripiprazole) 30mg tablets due to cross-contamination with other products. The recalled product consists of 30-count bottles with NDC 59148-011-13. Two specific lot numbers are affected: Lot # APS00423A (expiration date 07/31/2025) and Lot # APS00222A (expiration date 11/30/2024).
The FDA classified this as a Class III recall.
The affected product was distributed nationwide throughout the United States.
Consumers who have affected lots should consult their healthcare provider regarding their prescription.
The recalled product
- Product
- ABILIFY (ARIPIPRAZOLE)
- Brand
- ABILIFY
- Category
- Drug — Antipsychotic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot # APS00423A
- Exp 07/31/2025
- APS00222A
- Exp 11/30/2024
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · ABILIFY
- ModeratePrescription antipsychotic tablets Abilify recalled for cross-contamination with other products
FDA (Drugs) · 2024-05-01
- ModeratePrescription medication Abilify recalled for cross contamination with other products
FDA (Drugs) · 2024-05-01
- ModeratePrescription Drug Recall: ABILIFY Tablets Due to Cross Contamination
FDA (Drugs) · 2024-05-01
- ModerateBristol Myers Squibb Recalls Abilify Tablets Due to Manufacturing Error
FDA (Drugs) · 2013-03-13
Same hazard · cross contamination
See all →- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- HighFly By Jing creamy sesame noodles may contain undeclared peanut
FDA (Food) · 2026-06-03
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets 50 mg Recalled for API Cross-Contamination
FDA (Drugs) · 2026-05-27